A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

Clinical trial NCT05061563 · COMPLETED

Trial details

NCT number: NCT05061563
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men Hot Flashes

Start date: 2021-09-30
Primary completion: 2021-12-09
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.